NH TherAguix

NH TherAguix is a medical startup headquartered in Lyon, France, established in December 2015, focusing on utilizing nanoradiotherapy to treat cancer. The company’s leading drug is a nanoparticle named AGuIX, designed to selectively target solid tumors to enhance its localization and radiotherapy efficacy after intravenous injection.